Amorsa Therapeutics, Inc.
Pharmaceutical ManufacturingView the employees at
Amorsa Therapeutics, Inc.-
Michael Palfreyman Chief Scientific Officer at Amorsa Therapeutics, Inc.
-
Greater Boston
-
Top 1%
-
Greater Boston
-
Top 5%
-
Overview
Amorsa is pioneering the development of novel (patented) ketamine analogs for treating neuropsychiatric disorders including treatment resistant depression, PTSD and obsessive-compulsive disorder.